Patents by Inventor Howard Levin

Howard Levin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8515536
    Abstract: A method and apparatus for treatment of hypertension and heart failure by increasing vagal tone and secretion of endogenous atrial hormones by excitory pacing of the heart atria. Atrial pacing is done during the ventricular refractory period resulting in atrial contraction against closed AV valves, and atrial contraction rate that is higher than the ventricular contraction rate. Pacing results in the increased atrial wall stress. An implantable device is used to monitor ECG and pace the atria in a nonphysiologic manner.
    Type: Grant
    Filed: January 10, 2011
    Date of Patent: August 20, 2013
    Assignee: BackBeat Medical, Inc.
    Inventors: Howard Levin, Mark Gelfand
  • Patent number: 8340763
    Abstract: A method and apparatus for treatment of hypertension and heart failure by increasing secretion of endogenous atrial hormones by pacing of the heart atria. Atrial pacing is done during the ventricular refractory period resulting in premature atrial contraction that does not result in ventricular contraction. Pacing results in the atrial wall stress, peripheral vasodilation, ANP secretion. Concomitant reduction of the heart rate is monitored and controlled as needed with backup pacing.
    Type: Grant
    Filed: September 8, 2009
    Date of Patent: December 25, 2012
    Assignee: BackBeat Medical, Inc.
    Inventors: Howard Levin, Mark Gelfand
  • Publication number: 20120259309
    Abstract: A method of driving a toxin through a patient's kidneys, the method includes administering a diuretic to the patient to induce increased urine flow and collecting urine expelled by the patient. The amount of urine expelled by the patient is determined based on the collected urine. The patient is infused with fluid from a fluid source. Diuresis is induced by automatically adjusting the amount of fluid infused into the patient from the fluid source based on the determined amount of urine expelled by the patient to at least balance the amount of urine expelled by the patient with the amount of fluid infused into the patient to drive the toxin out of the patient's kidneys.
    Type: Application
    Filed: June 14, 2012
    Publication date: October 11, 2012
    Inventors: Mark Gelfand, Howard Levin
  • Publication number: 20120259308
    Abstract: A method includes setting a hydration goal and administering a diuretic to the patient to induce increased urine flow and collecting urine expelled by the patient. The amount of urine expelled by the patient is determined based on the collected urine. The patient is infused with fluid from a fluid source. The amount of fluid infused into the patient is determined. Diuresis is induced by automatically and continuously adjusting the amount of fluid infused into the patient from the fluid source to meet the hydration goal based on the set hydration goal, the determined amount of urine expelled by the patient and the fluid infused.
    Type: Application
    Filed: June 14, 2012
    Publication date: October 11, 2012
    Inventors: Mark Gelfand, Howard Levin
  • Publication number: 20120215272
    Abstract: A method and apparatus for treatment of heart failure by increasing secretion of endogenous naturetic hormones ANP and BNP such as by stimulation of the heart atria. Heart pacing is done at an atrial contraction rate that is increased and can be higher than the ventricular contraction rate. Pacing may include mechanical distension of the right atrial appendage. An implantable device is used to periodically cyclically stretch the walls of the appendage with an implanted balloon.
    Type: Application
    Filed: March 21, 2012
    Publication date: August 23, 2012
    Applicant: BackBeat Medical, Inc.
    Inventors: Howard Levin, Mark Gelfand
  • Publication number: 20120172680
    Abstract: A method and device for assessing, and treating patients having sympathetically mediated disease, such as cardiac, metabolic, or pulmonary disease involving chemoreceptor hyperactivity and heightened sympathetic tone by reducing chemosensor input to the nervous system.
    Type: Application
    Filed: December 28, 2011
    Publication date: July 5, 2012
    Applicant: G & L CONSULTING, LLC
    Inventors: Mark Gelfand, Howard Levin
  • Patent number: 8165674
    Abstract: A method and apparatus for treatment of heart failure by increasing secretion of endogenous naturetic hormones ANP and BNP such as by stimulation of the heart atria. Heart pacing is done at an atrial contraction rate that is increased and can be higher than the ventricular contraction rate. Pacing may include mechanical distension of the right atrial appendage. An implantable device is used to periodically cyclically stretch the walls of the appendage with an implanted balloon.
    Type: Grant
    Filed: March 1, 2006
    Date of Patent: April 24, 2012
    Assignee: BackBeat Medical, Inc.
    Inventors: Howard Levin, Mark Gelfand
  • Publication number: 20110172731
    Abstract: A method and apparatus for treatment of hypertension and heart failure by increasing vagal tone and secretion of endogenous atrial hormones by excitory pacing of the heart atria. Atrial pacing is done during the ventricular refractory period resulting in atrial contraction against closed AV valves, and atrial contraction rate that is higher than the ventricular contraction rate. Pacing results in the increased atrial wall stress. An implantable device is used to monitor ECG and pace the atria in a nonphysiologic manner.
    Type: Application
    Filed: January 10, 2011
    Publication date: July 14, 2011
    Applicant: G&L Consulting, LLC
    Inventors: Howard Levin, Mark Gelfand
  • Patent number: 7938817
    Abstract: A patient hydration system and method wherein a urine collection system is connected to the patient. An infusion system is also connected to the patient. An infusion pump is connected to a source of hydration fluid. A control subsystem is responsive to the amount of urine output by the patient and configured to automatically adjust the infusion rate of the infusion pump based on the urine output by the patient.
    Type: Grant
    Filed: September 9, 2004
    Date of Patent: May 10, 2011
    Assignee: PLC Medical Systems, Inc.
    Inventors: Mark Gelfand, Howard Levin
  • Patent number: 7869874
    Abstract: A method and apparatus for treatment of hypertension and heart failure by increasing vagal tone and secretion of endogenous atrial hormones by excitory pacing of the heart atria. Atrial pacing is done during the ventricular refractory period resulting in atrial contraction against closed AV valves, and atrial contraction rate that is higher than the ventricular contraction rate. Pacing results in the increased atrial wall stress. An implantable device is used to monitor ECG and pace the atria in a nonphysiologic manner.
    Type: Grant
    Filed: September 25, 2007
    Date of Patent: January 11, 2011
    Assignee: G&L Consulting, LLC
    Inventors: Howard Levin, Mark Gelfand
  • Publication number: 20100204677
    Abstract: A fluid management system for a patient includes a console for mounting on an IV pole. The console includes an input for setting a desired fluid balance for a set therapy duration. A weighing subsystem weighs the patient's urine output collected in a urine collection chamber and weighs a source of hydration fluid. An infusion pump is integrated with the console and is configured to pump hydration fluid from the source of hydration fluid into the patient. A controller in the console is responsive to the set desired fluid balance, the set therapy duration, and the weighing subsystem.
    Type: Application
    Filed: April 13, 2010
    Publication date: August 12, 2010
    Inventors: Mark Gelfand, Howard Levin
  • Publication number: 20100125288
    Abstract: A method and apparatus for treatment of chronic renal failure by reducing renal perfusion pressure. Treatment is performed by partial occlusion of renal artery. A device to constrict the renal artery may be implanted in the body of a patient and include a renal pressure sensor and a mechanical control applied the renal artery to adjustably constrict a cross sectional area of the artery.
    Type: Application
    Filed: November 17, 2009
    Publication date: May 20, 2010
    Applicant: G&L CONSULTING, LLC
    Inventors: Mark Gelfand, Howard Levin
  • Publication number: 20100094370
    Abstract: A method and apparatus for treatment of hypertension and heart failure by increasing secretion of endogenous atrial hormones by pacing of the heart atria. Atrial pacing is done during the ventricular refractory period resulting in premature atrial contraction that does not result in ventricular contraction. Pacing results in the atrial wall stress, peripheral vasodilation, ANP secretion. Concomitant reduction of the heart rate is monitored and controlled as needed with backup pacing.
    Type: Application
    Filed: September 8, 2009
    Publication date: April 15, 2010
    Applicant: G & L Consulting, LLC
    Inventors: Howard Levin, Mark Gelfand
  • Publication number: 20080188900
    Abstract: A method and apparatus to slow a heart rate with subthreshold electric stimulation of the SA node. Stimulation is applied at a specific time in the cardiac cycle and at a specific subthreshold level. To control the heart rate, the stimulating signal may be modified automatically based on physiologic feedbacks. Stimulation may be applied using an implantable pulse generator directly to the SA node of the heart.
    Type: Application
    Filed: December 21, 2007
    Publication date: August 7, 2008
    Applicant: G&L CONSULTING, LLC
    Inventors: Howard Levin, Mark Gelfand
  • Publication number: 20080132966
    Abstract: A method and apparatus for treatment of hypertension by electric stimulation of coronary artery baroreceptors wherein stimulation electrodes are implanted in the left coronary artery, periarterialy or in an adjacent coronary vein. Stimulation is non excitatory and does not cause heart contractions. Stimulation can be applied during the ventricular refractory period resulting in baroreceptor activation and subsequent reduction of blood pressure. An implantable device monitors ECG and applies to a field of stimulation of baroreceptors.
    Type: Application
    Filed: December 5, 2007
    Publication date: June 5, 2008
    Applicant: G&L CONSULTING, LLC
    Inventors: Howard Levin, Mark Gelfand
  • Publication number: 20080097273
    Abstract: A fluid removal apparatus comprising a blood removal catheter for insertion into a peripheral vein or artery and having a size 16 standard gage needle or less; a filter having a blood inlet port coupled to the blood removal catheter, a blood outlet port, an excess fluid removal port, and a blood flow passage with porous membrane which passes fluids to the fluid removal port and retains solutes of 60,000 Daltons or greater, and a blood return catheter for inserting into a peripheral vein or artery and having a size of 16 standard gage needle or less.
    Type: Application
    Filed: December 19, 2007
    Publication date: April 24, 2008
    Applicant: CHF SOLUTIONS, INC.
    Inventors: Howard Levin, Mark Gelfand, John O'Mahony, Hans-Dietrich Polaschegg
  • Publication number: 20080077187
    Abstract: A method and apparatus for treatment of hypertension and heart failure by increasing vagal tone and secretion of endogenous atrial hormones by excitory pacing of the heart atria. Atrial pacing is done during the ventricular refractory period resulting in atrial contraction against closed AV valves, and atrial contraction rate that is higher than the ventricular contraction rate. Pacing results in the increased atrial wall stress. An implantable device is used to monitor ECG and pace the atria in a nonphysiologic manner.
    Type: Application
    Filed: September 25, 2007
    Publication date: March 27, 2008
    Applicant: G&L CONSULTING, LLC
    Inventors: Howard Levin, Mark Gelfand
  • Publication number: 20080045877
    Abstract: A method and apparatus for replacement of renal function by periodically removing a substantial volume of patient's blood and simultaneously replacing it with the reconstituted blood. Reconstituted blood consists of the patient's own condensed blood cells and proteins diluted with the sterile physiologic solution. As a result, small molecules and excess water are periodically removed and discarded. Blood cells and proteins are safely stored to be used at the next therapy session.
    Type: Application
    Filed: August 15, 2007
    Publication date: February 21, 2008
    Applicant: G&L Consulting, LLC
    Inventors: Howard Levin, Mark Gelfand
  • Publication number: 20080033394
    Abstract: A patient hydration system with an infusion subsystem responsive to a source of hydration fluid for infusing the patient with hydration fluid. A urine output measurement subsystem determines the amount of urine output by the patient. A setting is received corresponding to an amount of urine to be output by the patient. When or after the urine output measurement subsystem indicates the set amount of urine has been output by the patient, the infusion subsystem is controlled to administer hydration fluid to the patient based on the patient's further urine output.
    Type: Application
    Filed: June 28, 2007
    Publication date: February 7, 2008
    Inventors: Mark Gelfand, Robert Rudko, Mark Tauscher, Howard Levin, Andy Halpert
  • Publication number: 20080027505
    Abstract: A method and apparatus for treatment of cervicogenic headaches by transvascular application of stimulation energy to nerves in the neck and head. A catheter equipped with electrodes is inserted into a vertebral or occipital vein in proximity to peripheral nerves that conduct pain signals. An external to the body or implanted generator is used to apply stimulation energy to the targeted nerves.
    Type: Application
    Filed: July 26, 2007
    Publication date: January 31, 2008
    Applicant: G&L CONSULTING, LLC
    Inventors: Howard Levin, Mark Gelfand